BIIB033 In Acute Optic Neuritis (AON)
NCT01721161
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Optic Neuritis
Interventions
BIOLOGICAL:
BIIB033 (anti-LINGO-1 mAb)
DRUG:
Placebo
Sponsor
Biogen